FDA Internal IoM Task Force Will Release Findings In December
This article was originally published in The Pink Sheet Daily
Executive Summary
A commissioner office-level task force has been charged with evaluating recommendations issued by the Institute of Medicine.
You may also be interested in...
FDA To Respond To IoM’s Rx Safety Recommendations
Commissioner von Eschenbach will detail how FDA plans to improve its oversight of drug risk issues.
FDA To Respond To IoM’s Rx Safety Recommendations
Commissioner von Eschenbach will detail how FDA plans to improve its oversight of drug risk issues.
Deputy Commissioner Scott Gottlieb To Leave FDA Jan. 16
Gottlieb will return to the American Enterprise Institute to work on health policy issues with former FDA/CMS chief Mark McClellan.